register

News & Trends - Pharmaceuticals

First locally-produced AstraZeneca COVID-19 vaccine doses released for rollout

Health Industry Hub | March 24, 2021 |

Pharma News: The first locally produced doses of AstraZeneca’s COVID-19 vaccine are now available for use in Australia. After approval by the Therapeutic Goods Administration (TGA) last night of the first four batches manufactured by CSL, more than 830,000 doses have been released. Additional batches will be approved and released for distribution on a weekly basis.

Ms Liz Chatwin, Country President, AstraZeneca Australia and New Zealand, said “This is a proud moment. Being able to manufacture the AstraZeneca vaccine here in Australia provides local certainty of supply in our efforts against COVID-19.

“CSL has delivered the locally produced doses ahead of their original schedule to support the Government’s vaccine rollout timetable. Australians can feel confident that this vaccine, locally made by our partner, CSL, meets the high standards of efficacy, safety and quality required for use in Australia,” she added.

CSL Chief Scientific Officer, Dr Andrew Nash said “It has taken a significant collaborative effort to get to this point and I would like to acknowledge all our partners including the Australian Government, AstraZeneca and the TGA for their dedication and rigour to deliver COVID-19 vaccines to the nation.”

Ms Chatwin continued “This is a terrific day for all Australians, and a very proud day for all of us at AstraZeneca. There are so many people who have been working behind the scenes each and every day for many months to get us to this point. 

“AstraZeneca signed an agreement with Oxford University less than one year ago, to develop and manufacture a COVID-19 vaccine that would address the global health emergency, providing broad and equitable access at no profit during the pandemic. Witnessing the vaccine being administered to millions of people around the world within months of its creation, and now in Australia, is proof of what science can do.”

Worldwide, AstraZeneca is providing close to three billion doses of the vaccine at no profit during the pandemic, ensuring broad and equitable access to the vaccine. In addition to agreements directly with governments, the COVAX (COVID-19 Vaccine Global Access) initiative is providing 170 million doses to 142 low and middle income countries.


News & Trends - MedTech & Diagnostics

Federal Health Minister meets with private hospital leaders to tackle sector reforms

Federal Health Minister meets with private hospital leaders to tackle sector reforms

Health Industry Hub | June 20, 2024 |

MedTech & Diagnostics News: In the past five years, 71 private hospital services have closed down as a result of […]

More


News & Trends - Pharmaceuticals

Medicines Australia warns against panic buying or stockpiling of drugs facing supply shortages

Medicines Australia warns against panic buying or stockpiling of drugs facing supply shortages

Health Industry Hub | June 20, 2024 |

Pharma News: Over 400 medicines are currently facing shortages nationwide, according to the Therapeutic Goods Administration (TGA). Among these, 39 […]

More


News & Trends - MedTech & Diagnostics

HCF partners with clinicians to optimise colonoscopy procedures in public hospitals

HCF partners with clinicians to optimise colonoscopy procedures in public hospitals

Health Industry Hub | June 20, 2024 |

MedTech & Diagnostics News: As Australia marks Bowel Cancer Awareness Month this June, the HCF Research Foundation highlights its support […]

More


Digital & Innovation

Australian AI-powered tool promises rapid stroke detection

Australian AI-powered tool promises rapid stroke detection

Health Industry Hub | June 20, 2024 |

Digital & Innovation: An Australian innovation promises to transform stroke care by enabling quicker intervention and improving patient outcomes through […]

More


This content is copyright protected. Please subscribe to gain access.